课题基金 / 基金详情

An attempt to form mutant CRM197 proteins of diphtheria toxin with neutralizing activity to heregulin.

An attempt to form mutant CRM197 proteins of diphtheria toxin with neutralizing activity to heregulin.
尝试形成对调蛋白具有中和活性的白喉毒素突变型 CRM197 蛋白。
批准号:
07557335
负责人:
MEKADA Eisuke
金额:
$1.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

MEKADA Eisuke的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have found that diphtheria toxin (DT) bind to the EGF-like domain of diphtheria toxin receptor/membrane-anchored form of heparin-binding EGF-like growth factor (proHB-EGF). DT,or its non-toxic mutant CRM197, inhibits the binding of HB-EGF to EGF receptor, resulting in inhibition of mitogenic activity of HB-EGF.The aim of this work is to produce mutant forms of CRM197 of diphtheria toxin with neutralizing activity to heregulin. We have obtained the following results.(1) Analysis of the DT-binding site on the EGF-like domain of HB-EGFTo form heregulin-binding CRM197, DT-binding site on EGF-like domain of HB-EGF was precisely determined. We introduced single point mutations for 10 amino acids within the EGF-like domain. Mutation at F115, L127 or E141 greatly decreased the DT-binding activityof HB-EGF,but mutations for the remaining 7 amino acids did not show large effect.(2) Construction of three-dimentional structure model of the EGF-like domain of HB-EGFThree-dimentional structure model of the EGF-like domain of HB-EGF was constructed based on the NMR data of EGF and TGFalpha. The model indicated that amino acid residues F115, L127 and E141 exist on the same side of the molecule, suggesting that HB-EGF interacts with DT at this side.These results is critical to construct heregulin-binding CRM197. Further studies are in progress.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Nakamura, K.: "Membrane anchored heparin-binding EGF-like growth factor and DRAP27/CD9 form a complex with integrin 3 l at cell-cell contact sites." J. Cell Biol.129. 1691-1705 (1995)
Nakamura, K.:“膜锚定的肝素结合 EGF 样生长因子和 DRAP27/CD9 在细胞与细胞接触位点与整合素 3 l 形成复合物。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tsuneoka,M.: "c-myc activates RCC1 gene expression through E-box elements." Oncogene. (in perss).
Tsuneoka,M.:“c-myc 通过 E-box 元件激活 RCC1 基因表达。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mitamura,T.: "Diphtheria toxin binds to the EGF-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor, and inhibits specifically its mitogenic activity." J.Biol.Chem.270. 1015-1019 (1995)
Mitamura,T.:“白喉毒素与人肝素结合 EGF 样生长因子/白喉毒素受体的 EGF 样结构域结合,并特异性抑制其促有丝分裂活性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
12
    The role of HB-EGF in cancer cell proliferation and malignancy
    • 批准号:
      23240126
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.45万
    • 财政年份:
      2011
    • 负责人:
      MEKADA Eisuke
    • 依托单位:
    Identification of host cell factors involved in diphtheria toxin sensitivity by using shRNA library.
    • 批准号:
      20390127
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.48万
    • 财政年份:
      2008
    • 负责人:
      MEKADA Eisuke
    • 依托单位:
    Identification of genes involved in the ectodomain sheddingof HB-EGF
    • 批准号:
      18370079
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.05万
    • 财政年份:
      2006
    • 负责人:
      MEKADA Eisuke
    • 依托单位:
    Cell function regulation by membrane-anchored growth factors
    • 批准号:
      17014057
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $65.47万
    • 财政年份:
      2005
    • 负责人:
      MEKADA Eisuke
    • 依托单位:
    国内基金
    海外基金
    HB-EGF/EGFR信号介导的染色质重塑诱发OSF形成的作用及机制研究
    • 批准号:
      2025JJ50539
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      李宁
    • 依托单位:
    乙型肝炎病毒增强HB-EGF转录及m6A甲基化修饰促进血管生成
    • 批准号:
      82302503
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      吴淑香
    • 依托单位:
    脱落酶ADAMDEC1通过HB-EGF形成正反馈环路促进类风湿关节炎血管新生的机制研究
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      邹玉明
    • 依托单位:
    CD9负调控HB-EGF/EGFR信号在创缘表皮细胞伪足形成中的作用与机制研究